imiquimod has been researched along with Cicatrix in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (62.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Brennan-Crispi, D; Cotsarelis, G; Johnson, NM; Kim, HS; Leung, DH; Leung, TH; Miller, C; Rosenbach, M; Spencer, CA; Wei, JJ; Zheng, Y | 1 |
Bayat, A; McGeorge, D; Sidgwick, GP | 1 |
Mrowietz, U; Seifert, O | 1 |
Barbosa Filho, RA; Barbosa Filho, RC; de C Rocha, JL; de Mesquita, CJ; Fechine, FV; Leite Filho, JA; Leite, JA; Leite, JG | 1 |
Andrades, P; Benitez, S; Prado, A; UmaƱa, M | 1 |
Berman, B; Frankel, S; Nouri, K; Poochareon, V; Ramirez, CC; Villa, AM | 1 |
Berman, B | 1 |
Flowers, F | 1 |
3 review(s) available for imiquimod and Cicatrix
Article | Year |
---|---|
A comprehensive evidence-based review on the role of topicals and dressings in the management of skin scarring.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Bandages; Cicatrix; Humans; Imiquimod; Plant Extracts; Skin Diseases; Vitamins; Wound Healing | 2015 |
Keloid scarring: bench and bedside.
Topics: Adult; Aminoquinolines; Cicatrix; Female; Genetic Predisposition to Disease; Humans; Imiquimod; Immunity, Cellular; Interleukin-10; Keloid; Polymorphism, Genetic; Pregnancy; Quality of Life; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2009 |
Scientific rationale: combining imiquimod and surgical treatments for basal cell carcinomas.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cicatrix; Combined Modality Therapy; Humans; Imiquimod; Skin Neoplasms | 2008 |
2 trial(s) available for imiquimod and Cicatrix
Article | Year |
---|---|
Scar management after breast surgery: preliminary results of a prospective, randomized, and double-blind clinical study with aldara cream 5% (imiquimod).
Topics: Aminoquinolines; Cicatrix; Double-Blind Method; Female; Humans; Imiquimod; Interferon Inducers; Mammaplasty; Prospective Studies | 2005 |
Double-blind, randomized, placebo-controlled, prospective study evaluating the tolerability and effectiveness of imiquimod applied to postsurgical excisions on scar cosmesis.
Topics: Adolescent; Adult; Aminoquinolines; Child; Cicatrix; Double-Blind Method; Esthetics; Female; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Nevus, Pigmented; Ointments; Prospective Studies; Skin Neoplasms; Treatment Outcome | 2005 |
3 other study(ies) available for imiquimod and Cicatrix
Article | Year |
---|---|
Activation of TRPA1 nociceptor promotes systemic adult mammalian skin regeneration.
Topics: Adjuvants, Immunologic; Animals; Cicatrix; Female; Imiquimod; Inflammation; Intraepithelial Lymphocytes; Male; Mice, Inbred C57BL; Mice, SCID; Mice, Transgenic; Regeneration; Skin; Skin Physiological Phenomena; TRPA1 Cation Channel; Wound Healing | 2020 |
Effect of imiquimod on partial-thickness burns.
Topics: Administration, Cutaneous; Aminoquinolines; Animals; Body Mass Index; Burns; Cicatrix; Collagen; Drug Evaluation, Preclinical; Imiquimod; Immunologic Factors; Male; Rats; Rats, Wistar; Severity of Illness Index; Skin; Wound Healing | 2010 |
Imiquimod in the treatment of actinic keratoses and other intraepithelial neoplasms.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Bowen's Disease; Cicatrix; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratosis; Paget Disease, Extramammary; Photochemotherapy; Pruritus; Randomized Controlled Trials as Topic; Skin Neoplasms | 2002 |